U.S. markets closed
  • S&P Futures

    3,268.00
    -7.00 (-0.21%)
     
  • Dow Futures

    27,002.00
    -53.00 (-0.20%)
     
  • Nasdaq Futures

    10,949.00
    -40.00 (-0.36%)
     
  • Russell 2000 Futures

    1,478.70
    -4.10 (-0.28%)
     
  • Crude Oil

    39.57
    +0.26 (+0.66%)
     
  • Gold

    1,913.10
    +2.50 (+0.13%)
     
  • Silver

    24.64
    +0.25 (+1.02%)
     
  • EUR/USD

    1.1766
    -0.0007 (-0.06%)
     
  • 10-Yr Bond

    0.6710
    -0.0230 (-3.31%)
     
  • Vix

    27.78
    +1.95 (+7.55%)
     
  • GBP/USD

    1.2811
    -0.0007 (-0.05%)
     
  • USD/JPY

    104.4940
    -0.1860 (-0.18%)
     
  • BTC-USD

    10,463.54
    +25.82 (+0.25%)
     
  • CMC Crypto 200

    213.19
    -22.40 (-9.51%)
     
  • FTSE 100

    5,804.29
    -202.76 (-3.38%)
     
  • Nikkei 225

    23,360.30
    +40.90 (+0.18%)
     

Cns Pharmaceuticals Inc (CNSP) CFO Christopher Downs Bought $289,680 of Shares

GuruFocus.com

- By insider

CFO of Cns Pharmaceuticals Inc (30-Year Financial, Insider Trades) Christopher Downs (insider trades) bought 142,000 shares of CNSP on 08/24/2020 at an average price of $2.04 a share. The total cost of this purchase was $289,680.


CNS Pharmaceuticals Inc has a market cap of $41.120 million; its shares were traded at around $2.50 .

CFO Recent Trades:

  • CFO Christopher Downs bought 142,000 shares of CNSP stock on 08/24/2020 at the average price of $2.04. The price of the stock has increased by 22.55% since.

For the complete insider trading history of CNSP, click here

.This article first appeared on GuruFocus.